AUTL - Autolus Therapeutics EPS beats by $0.04 misses on revenue November, 03 2021 07:37 AM Autolus Therapeutics plc Autolus Therapeutics (NASDAQ:AUTL): Q3 GAAP EPS of -$0.47 beats by $0.04. Revenue of $0.24M (-64.7% Y/Y) misses by $0.01M. Press Release For further details see: Autolus Therapeutics EPS beats by $0.04, misses on revenue